Tag Archives: Vietnam

Willingness to participate in clinical trials in Vietnam

J. Pharm. Pharmacogn. Res., vol. 10, no. 5, pp. 791-799, September-October 2022.

Original Article

Willingness to participate in clinical trials: A cross-sectional analysis in Ho Chi Minh City, Vietnam

[Disposición para participar en ensayos clínicos: Un análisis transversal en la ciudad de Ho Chi Minh, Vietnam]

Thoai N. Dang, Tran T.T. Bao, Chau N.D. Quynh, Trung V. Quang*

Faculty of Pharmacy, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, 700000, Vietnam.

*E-mail: trungvq@pnt.edu.vn

Abstract

Context: Clinical trial is an experiment on comparable groups of human beings which evaluates the efficacy of a treatment or medical intervention by comparing the effects with other testing treatments or control treatments. Clinical trials help develop alternative treatment solutions or a preventative method for disease as well as support participants with medical and healthcare services during the trial period. Other benefits of clinical trials include gaining information, ensuring health issues, detecting early disease symptoms, and reducing medical services costs.

Aims: To evaluate willingness to participate (WTP) in clinical trials (CT) in Ho Chi Minh city and examine the factors associated with it.

Methods: A cross-sectional study was conducted through the online sampling method and gathered 581 valid responses during two weeks in February 2022.

Results: Among 581 respondents, 71.6% stated they were willing to participate in CT, while 48.2% stated that they would let their family enroll. WTP in CT was higher in participants of younger age, single, not having children, healthy, and without chronic disease. Vietnamese age was associated with WTP in CT.

Conclusions: Assessing WTP in CT helps state management agencies, organizations and research institutes design suitable CT models and increase the voluntary participation rate in CT.

Keywords: clinical trial; Ho Chi Minh city; public; Vietnam; willingness to participate.

jppres_pdf_free

Resumen

Contexto: El ensayo clínico es un experimento en grupos comparables de seres humanos que evalúan la eficacia de un tratamiento o intervención médica comparando los efectos con otros tratamientos de prueba o tratamientos de control. Los ensayos clínicos ayudan a desarrollar una solución de tratamiento alternativa o un método preventivo para la enfermedad, así como también brindan apoyo a los participantes con servicios médicos y de atención médica durante el período de prueba. Otros beneficios de los ensayos clínicos incluyen obtener información, garantizar problemas de salud, detectar síntomas tempranos de enfermedades y reducir el costo de los servicios médicos.

Objetivos: Evaluar la disposición a participar (WTP) en ensayos clínicos (CT) en la ciudad de Ho Chi Minh y examinar los factores asociados con ella.

Métodos: Se realizó un estudio transversal a través del método de muestreo en línea y se recolectaron 581 respuestas válidas durante dos semanas en febrero de 2022.

Resultados: Entre 581 encuestados, el 71,6% afirmó estar dispuesto a participar en CT mientras que el 48,2% afirmó estar dispuesto a dejar que su familia se inscriba. La DAP en CT fue mayor en participantes de menor edad, solteros, sin hijos, sanos y sin enfermedad crónica. La edad vietnamita se asoció con WTP en CT.

Conclusiones: Evaluar la WTP en CT ayuda a las agencias estatales de gestión, organizaciones e institutos de investigación a diseñar modelos de CT adecuados y aumentar la tasa de participación voluntaria en CT.

Palabras Clave: Ciudad Ho Chi Minh; ensayo clínico; público; Vietnam; voluntad de participar.

jppres_pdf_free

Citation Format: Thoai ND, Tran TTB, Chau NDQ, Trung VQ (2022) Willingness to participate in clinical trials: A cross-sectional analysis in Ho Chi Minh City, Vietnam. J Pharm Pharmacogn Res 10(5): 791–799.
References

Ahram M, Farkouh A, Haddad M, Kalaji Z, Yanis A (2020) Knowledge of, attitudes to and participation in clinical trials in Jordan: a population-based survey. East Mediterr Health J 26: 539–546.

Ali J, Andrews JE, Somkin CP, Rabinovich CE (2015) Harms, benefits, and the nature of interventions in pragmatic clinical trials. Clin Trials 12: 467–475.

Almutairi AF, Almutairi BM, Alturki AS, Adlan AA, Salam M, Al-Jeraisy MI, Balkhy HH (2019) Public motives and willingness to participate in first-in-human clinical trials in Saudi Arabia: A new era in the making. J Infect Public Health 12: 673–680.

Al-Tannir MA, El-Bakri N, Abu-Shaheen AK (2016) Knowledge, attitudes and perceptions of Saudis towards participating in clinical trials. PLoS One 11: e0143893.

Chu SH, Kim EJ, Jeong SH, Park GL (2015) Factors associated with willingness to participate in clinical trials: a nationwide survey study. BMC Public Health 15: 1–8.

Comis RL, Miller JD, Aldigé CR, Krebs L, Stoval E (2003) Public attitudes toward participation in cancer clinical trials. J Clin Oncol 21: 830–835.

Farha RA, Alzoubi KH, Khabour OF, Mukattash TL (2020) Factors influencing public knowledge and willingness to participate in biomedical research in Jordan: A national survey. Patient Prefer Adherence 14: 1373.

Featherstone K, Donovan JL (2002) “Why don’t they just tell me straight, why allocate it?” The struggle to make sense of participating in a randomised controlled trial. Soc Sci Med 55: 709–719.

Goldman RD, Staubli G, Cotanda CP, Brown JC, Hoeffe J, Seiler M, Gelernter R, Hall JE, Griffiths MA, Davis AL (2021) Factors associated with parents’ willingness to enroll their children in trials for COVID-19 vaccination. Hum Vaccines Immunother 17: 1607–1611.

Guedj M, Ballester S, Kamar N, Rostaing L, Donckier V, Goldman M, Cambon‐Thomsen A (2013) Patients’ motives for consenting or refusing to participate in a clinical trial in organ transplantation. Clin Transplant 27: 724–731.

Harris Y, Gorelick PB, Samuels P, Bempong I (1996) Why African Americans may not be participating in clinical trials. J Natl Med Assoc 88: 630.

Kamath A, As K (2014) Willingness to participate in a clinical trial and understanding of informed consent information among medical students. Indian J Med Ethics 11: 16–18.

Kaplan CP, Nápoles AM, Narine S, Gregorich S, Livaudais-Toman J, Nguyen T, Leykin Y, Roach M, Small EJ (2015) Knowledge and attitudes regarding clinical trials and willingness to participate among prostate cancer patients. Contemp Clin Trials 45: 443–448.

Kukreja JB, Thompson Jr IM, Chapin BF (2019) Organizing a clinical trial for the new investigator. In: Urologic Oncology: Seminars and Original Investigations 37: 336–339.

Lim Y, Lim JM, Jeong WJ, Lee KH, Keam B, Kim TY, Kim TM, Han SW, Oh DY, Kim DW (2017) Korean cancer patients’ awareness of clinical trials, perceptions on the benefit and willingness to participate. Cancer Res Treat 49: 1033.

Liu J, Hou W, Gönen M, Seluzicki C, Li SQ, Mao JJ (2020) Symptom burden and willingness to participate: implications for herbal clinical trials in lung cancer. Ann Palliat Med 10: 1895–1903.

Locock L, Smith L (2011) Personal benefit, or benefiting others? Deciding whether to take part in clinical trials. Clin Trials 8: 85–93.

Meinert CL (2012) ClinicalTrials: design, conduct and analysis, 2nd edn. New York, USA: Oxford University Press.

Moorcraft SY, Marriott C, Peckitt C, Cunningham D, Chau I, Starling N, Watkins D, Rao S (2016) Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey. Trials 17: 1–12.

National Institute on Aging (2017) Clinical Trials: Benefits, Risks, and Safety: National Institute on Aging. U.S. Department of Health & Human Services. Available: https://www.nia.nih.gov/health/clinical-trials-benefits-risks-and-safety [Accessed 18 August 2021].

National Institute on Aging (2020) What are Clinical Trials and Studies? U.S. Department of Health & Human Services. Available: https://www.nia.nih.gov/health/what-are-clinical-trials-and-studies [Accessed 18 August 2021].

Nipp RD, Hong K, Paskett ED (2019) Overcoming barriers to clinical trial enrollment. Am Soc Clin Oncol Educ Book 39: 105–114.

Novitzke MJ (2008) The significance of clinical trials. J Vasc Interv Neurol 1: 31.

Raheja D, Davila EP, Johnson ET, Deović R, Paine M, Rouphael N (2018) Willingness to participate in vaccine-related clinical trials among older adults. Int J Environ Res Public Health 15: 1743.

Ramalhinho AC, Castelo-Branco M (2021) Preparation of an Academic Clinical Trial. In: Sousa  (eds) DNA Vaccines. New York, Springer, pp. 317–330.

Uhlmann S, Milloy MJ, Ahamad K, Nguyen P, Kerr T, Wood E, Richardson L (2015) Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugs. Am J Addict 24: 368–373.

Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME (2019) Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. J Natl Cancer Inst 111: 245–255.

Vo NTT, Phan TND, Vo TQ (2017) Direct medical costs of dengue fever in Vietnam: A retrospective study in a tertiary hospital. Malays J Med Sci 24: 66.

World Health Organization (2020) Clinical trials. Available: https://www.who.int/news-room/q-a-detail/clinical-trials [Accessed 18 August 2021].

Zvonareva O, Kutishenko N, Kulikov E, Martsevich S (2015) Risks and benefits of trial participation: A qualitative study of participants’ perspectives in Russia. Clin Trials 12: 646–653.

© 2022 Journal of Pharmacy & Pharmacognosy Research (JPPRes)

Antibiotic order form in a tertiary hospital in Vietnam



J Pharm Pharmacogn Res 9(4): 474-483, 2021.

Original article

The use of an antibiotic order form in a tertiary hospital: Influence on physicians’ prescribing patterns

[El uso de un formulario de pedido de antibióticos en un hospital de tercer nivel: influencia en los patrones de prescripción de los médicos]

Duc Chien Vo1, Tuan Anh Mai2, Thu Thao Nguyen3, Dang Thoai Nguyen4, Thi Ha Vo3,4*

1Department of Respiratory Medicine, Nguyen Tri Phuong Hospital, Ho Chi Minh, V-70000, Vietnam.

2Department of Pharmacy, Hanoi Pharmacy University, Ha Noi, 100000, Vietnam.

3Department of Pharmacy, Nguyen Tri Phuong Hospital, Ho Chi Minh, V-70000, Vietnam.

4Faculty of Pharmacy, Pham Ngoc Thach University of Medicine, Ho Chi Minh, V-70000, Vietnam.

*E-mail: havt@pnt.edu.vn

Abstract

Context: Vietnam is one of the countries at the high alert of antibiotic resistance.

Aims: To evaluate the compliance rate and changes in physicians’ prescribing patterns in patients with community-acquired pneumonia (CAP) before and after using the antibiotic order form (AOF) in a tertiary hospital.

Methods: 120 inpatient medical records having antibiotic use and 115 patient medical records diagnosed with CAP at a Department of Respiratory Medicine during 3 months before and 3 months after using the AOF were retrospectively collected for assessment.

Results: The compliance rate was 92%, and the average rate of filling in information fields was 58%. Comparison of prescribing behavior of CAP in control and intervention group showed that the rate of bacterial culture increased from 70% to 77% (p = 0.690), in which the rate of culture prior prescribing administration increased from 14% to 45% (p < 0.001), the initial antibiotic regimen with narrow-spectrum increased from 26% to 36% (p = 0.353), the proportion of patients improved clinically after 72 hours increased from 64% to 89% (p = 0.138), and the de-escalation decreased from 23% to 20% (p = 0.713). The treatment failure at hospital discharge decreased from 12% to 6% (p = 0.447). However, the length of treatment and the days of antibiotic treatment were not significantly different.

Conclusions: The compliance rate was high, but the AOF filling rate was incomplete. Improving prescribing patterns and treatment efficacy in CAP patients is a suggestion to combine the AOF into multifaceted interventional efforts for specific patients.

Keywords: antibiotic order form; antibiotic stewardship program; community acquired pneumonia; prescribing; Vietnam.

This image has an empty alt attribute; its file name is jppres_pdf_free.png
Resumen

Contexto: Vietnam es uno de los países en alerta máxima de resistencia a los antibióticos.

Objetivos: Evaluar la tasa de cumplimiento y el cambio en los patrones de prescripción de los médicos en pacientes con neumonía adquirida en la comunidad (NAC) antes y después de usar el formulario de pedido de antibióticos (AOF) en un hospital terciario.

Métodos: Se recolectaron retrospectivamente 120 historias clínicas de pacientes hospitalizados con uso de antibióticos y 115 historias clínicas de pacientes diagnosticados con NAC en un Departamento de Medicina Respiratoria durante los 3 meses antes y 3 meses después de usar la AOF para su evaluación.

Resultados: La tasa de cumplimiento fue del 92% y la tasa promedio de llenado de los campos de información fue del 58%. La comparación del comportamiento de prescripción de CAP en el grupo de control y de intervención mostró que la tasa de cultivo bacteriano aumentó del 70% al 77% (p = 0,690), en el que la tasa de cultivo antes de la administración de prescripción aumentó del 14% al 45% (p < 0,001 ), el régimen antibiótico inicial con espectro estrecho aumentó del 26% al 36% (p = 0,353), la proporción de pacientes que mejoraron clínicamente después de 72 horas aumentó del 64% al 89% (p = 0,138) y la disminución del 23% al 20% (p = 0,713). El fracaso del tratamiento al alta hospitalaria disminuyó del 12% al 6% (p = 0,447). Sin embargo, la duración del tratamiento y los días de tratamiento con antibióticos no fueron significativamente diferentes.

Conclusiones: La tasa de cumplimiento fue alta, pero la tasa de llenado de la AOF fue incompleta. Mejorar los patrones de prescripción y la eficacia del tratamiento en pacientes con NAC es una sugerencia para combinar la AOF en esfuerzos intervencionistas multifacéticos para pacientes específicos.

Palabras Clave: formulario pedido antibióticos; neumonía adquirida en la comunidad; prescribir; programa administración antibióticos; Vietnam.

This image has an empty alt attribute; its file name is jppres_pdf_free.png
Citation Format: Vo DC, Mai TA, Nguyen TT, Nguyen DT, Vo TH (2021) The use of an antibiotic order form in a tertiary hospital: Influence on physicians’ prescribing patterns. J Pharm Pharmacogn Res 9(4): 474–483.

© 2021 Journal of Pharmacy & Pharmacognosy Research (JPPRes)

Pharmacists’ patient care competency

J Pharm Pharmacogn Res 9(1): 68-77, 2021.

Original Article

Pharmacist perceptions of patient care competency: A survey in Vietnam

[Percepciones de los farmacéuticos sobre la competencia en el cuidado del paciente: una encuesta en Vietnam]

Vo T. Ha1,2,Tang V. Hai1,Ngo M. Xuan3,Nguyen T. L. Huong4*

1Faculty of Pharmacy, Pham Ngoc Thach University of Medicine, Ho Chi Minh, V-70000, Vietnam.

2Department of Pharmacy, Nguyen Tri Phuong Hospital, Ho Chi Minh, V-70000, Vietnam.

3Faculty of Medicine, Pham Ngoc Thach University of Medicine, Ho Chi Minh, V-70000, Vietnam.4Department of Clinical Pharmacy, Hanoi University of Pharmacy, Ha Noi, V-100000, Vietnam.

*E-mail: huongntl@hup.edu.vn

Abstract

Context: In order to perform effectively in professional practice, a pharmacist should demonstrate crucial competencies on delivery of patient care.

Aims: To evaluate current pharmacists’ perceptions on their delivery of patient care competencies.

Methods: The evaluation divided into 8 domains of competencies with 35 behavioral statements was distributed to hospital and community pharmacists. Respondents were asked to self-evaluate their competencies on a four-point Likert scale.

Results: Of 207 responses returned, there were 106 hospital pharmacists and 89 community pharmacists. The mean score ranged from 2.2 to 3.5. Respondents perceived themselves as the most competent in “Drug Specific Issues” and “Provision of drug product” cluster (3.5 ± 0. 68, 3.3 ± 0.84, respectively), whereas the lowest performance was noted in “Patient Consultation” and “Evaluation of Outcomes” (2.8 ± 1.01 and 2.8 ± 0.88, respectively). Pharmacists demonstrated the best performance in the behavioral statements pertaining to the “Appropriate route is ensured” (3.6 ± 0.63). The two behaviors with the lowest performance were “Recording Consultations” (2.2 ± 1.02) and “Record of contributions” (2.7 ± 0.93). There were no statistically significant differences in the competence cluster scores in terms of types of pharmacists, sex, age, education level, years of experience (p>0.05).

Conclusions: This research represents the first self-assessment of Vietnamese pharmacists in patient care practice. Areas for additional professional education which were determined include recording patient consultation, obtaining patient consent, prioritization of drug-related problems, referrals to doctors, and assessment of patient outcomes.

Keywords: competency; education; pharmacist; self-assessment; Vietnam.

Resumen

Contexto: Para desempeñarse eficazmente en la práctica profesional, un farmacéutico debe demostrar competencias cruciales en la prestación de atención al paciente.

Objetivos: Evaluar las percepciones de los farmacéuticos actuales sobre su prestación de competencias de atención al paciente.

Métodos: La evaluación dividida en 8 dominios de competencias con 35 declaraciones de comportamiento se distribuyó a los farmacéuticos hospitalarios y comunitarios. Se pidió a los encuestados que autoevaluaran sus competencias en una escala Likert de cuatro puntos.

Resultados: De 207 respuestas devueltas, había 106 farmacéuticos de hospital y 89 farmacéuticos comunitarios. La puntuación media osciló entre 2,2 y 3,5. Los encuestados se percibieron a sí mismos como los más competentes en el grupo de “Problemas específicos de medicamentos” y “Suministro de medicamentos” (3,5 ± 0,68, 3,3 ± 0,84, respectivamente), mientras que el rendimiento más bajo se observó en “Consulta del paciente” y “Evaluación de Resultados” (2,8 ± 1,01 y 2,8 ± 0,88, respectivamente). Los farmacéuticos demostraron el mejor desempeño en las declaraciones de comportamiento correspondientes a la “Se garantiza la ruta adecuada” (3,6 ± 0,63). Los dos comportamientos con menor desempeño fueron “Registro de consultas” (2,2 ± 1,02) y “Registro de contribuciones” (2,7 ± 0,93). No hubo diferencias estadísticamente significativas en las puntuaciones del grupo de competencias en términos de tipos de farmacéuticos, sexo, edad, nivel educativo, años de experiencia (p>0,05).

Conclusiones: Esta investigación representa la primera autoevaluación de los farmacéuticos vietnamitas en la práctica de atención al paciente. Las áreas de educación profesional adicional que se determinaron incluyen el registro de la consulta del paciente, la obtención del consentimiento del paciente, la priorización de los problemas relacionados con los medicamentos, las derivaciones a los médicos y la evaluación de los resultados del paciente.

Palabras Clave: autoevaluación; competencia; educación; farmacéutico; Vietnam.

Citation Format: Ha VT, Hai TV, Xuan NM, Huong NTL (2021) Pharmacist perceptions of patient care competency: A survey in Vietnam. J Pharm Pharmacogn Res 9(1): 69–77.

© 2021 Journal of Pharmacy & Pharmacognosy Research (JPPRes)